Novo Nordisk has the potential to maintain more consistent revenue growth throughout next year. There is an indication that ...

While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...

Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...

Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled WEgovy Real ...

The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for ...

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...

The European Medicines Agency (EMA) has recommended extending the use of Mounjaro to younger patients with diabetes, ...

PureHealth Research today announced the launch of its new line of vein health supplements, offering a natural approach to supporting healthy circulation and promoting the appearance of ...

Laser by Aleya, a provider of New York laser and electrolysis hair removal services, has announced a continued investment in personalized, education-driven skincare treatments aimed at empowering ...

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...

Morgan Stanley said that the company is a distinctive play on shifting lifestyle dynamics, and is largely insulated from ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...